Overcome The Increasing Complexity Of Clinical Logistics
Clinical trials have become more complex than ever. Although there is still some debate around exactly how complex they have become (the April 28, 2016 Pharmaceutical Outsourcing Monitorhas some good insights), trials today seem to have more endpoints, procedures, eligibility criteria, protocol amendments, and investigator sites than just 10 years ago. Add adaptive trials to the mix, and clinical supply executives have more to worry about than ever before.
In recent years, far more variables have entered the equation as studies have become more complex and have served to shine a light on limitations that exist within the traditional model and its lack of flexibility. Clark notes biologics are entering R&D pipelines in increasing numbers, and most require special handling and cold chain solutions. Adaptive trial designs, which allow for mid-study changes such as dosing requirements, are also throwing a wrench into the traditional logistics equation.
Source: Clinical Leader
